Home › Neurofibrosarcoma
Pag-aaral pangklinika para sa Neurofibrosarcoma na nagre-recruit sa U.S.
14 pag-aaral para sa Neurofibrosarcoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Washington, DC6 pag-aaral
- New York City, NY6 pag-aaral
- St. Louis, MO4 pag-aaral
- Boston, MA4 pag-aaral
- Houston, TX3 pag-aaral
- Cincinnati, OH3 pag-aaral
- Chicago, IL3 pag-aaral
- Mountain View, CA3 pag-aaral
- Edison, NJ3 pag-aaral
- Queens, NY3 pag-aaral
Ayos sa estado
- California3 pag-aaral
- Illinois3 pag-aaral
- Maryland4 pag-aaral
- Massachusetts5 pag-aaral
- Missouri4 pag-aaral
- New Jersey3 pag-aaral
- New York6 pag-aaral
- Ohio4 pag-aaral
- Tennessee4 pag-aaral
- Texas5 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 12 hanggang 120 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT04222413DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins
Nagre-recruitObservasyonal na pag-aaral
Edad 1 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07298083Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05732831Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05245500Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
Nagre-recruitObservasyonal na pag-aaral
Edad 3 hanggang 120 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06222203Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
Nagre-recruitPhase 2
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05253131Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT07549022SPEARHEAD-3 Pediatric Study
Nagre-recruitPhase 1/2
Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05642455NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Nagre-recruitPhase 1/2
Hanggang edad 30 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06239272Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT06735820B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Nagre-recruitPhase 1
Hanggang edad 21 · Lahat ng kasarian · Na-update May 19, 2026 · NCT04897321A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Nagre-recruitPhase 2
12 Months · Lahat ng kasarian · Na-update May 6, 2026 · NCT05985161Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Mar 9, 2026 · NCT03141021A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)
Nagre-recruitPhase 2
Edad 16 pataas · Lahat ng kasarian · Na-update Peb 5, 2026 · NCT04872543Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.